EODData

FRA, 1S1: VIRIDIAN THERAPEUTICS

14 Aug 2026
LAST:

18.70

CHANGE:
 1.10
OPEN:
18.90
HIGH:
18.90
ASK:
0.00
VOLUME:
0
CHG(%):
5.56
PREV:
19.80
LOW:
18.70
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
14 Aug 2618.9018.9018.7018.700
13 Aug 2619.8019.8019.8019.800
12 Aug 2619.8019.8019.8019.800
07 Aug 2619.4019.9019.4019.90250
06 Aug 2617.6017.6017.6017.600
05 Aug 2618.0018.0018.0018.000
04 Aug 2616.7016.7016.7016.700
03 Aug 2616.4016.4016.4016.400
31 Jul 2617.3017.3017.3017.300
30 Jul 2617.3017.3017.3017.300

PROFILE

Name:VIRIDIAN THERAPEUTICS
About:Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. The company's product pipeline includes veligrotug, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R monoclonal antibodies targeting IGF-1R and engineered of half-life extension technology, which is in Phase 3 clinical trial for the treatment of TED. It also develops portfolio of engineered anti-neonatal Fc receptor inhibitors, such as VRDN-006 and VRDN-008 for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:221 Crescent Street, Waltham, MA, United States, 02453
Website:https://www.viridiantherapeutics.com
ISIN:US92790C1045
LEI:549300C775BNYF550E70

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-5.27 
Forward P/E:-6.53 
PEG Ratio:-1.53 
Price to Sales:26.94 
Price to Book:4.01 
Operating Margin:-823.89 
Return on Assets:-0.33 
Return on Equity:-0.58 
Revenue:62.18M 
Shares:81.66M 
Market Cap:1.527B 

TECHNICAL INDICATORS

MA5:19.162.5%
MA10:18.153.0%
MA20:17.347.9%
MA50:16.1915.5%
MA100:15.6819.2%
MA200:20.288.4%
STO9:65.71
STO14:65.71
RSI14:63.89 
WPR14:-34.29
MTM14:1.90
ROC14:0.11 
ATR:0.51 
Week High:19.906.4%
Week Low:18.700.0%
Month High:19.906.4%
Month Low:15.508.4%
Year High:28.5852.8%
Year Low:11.2067.0%
Volatility:18.33 

RECENT SPLITS

Date Ratio
13 Nov 20201-15
07 Nov 20161-15